Bristol-Myers Squibb traded at $75.96 this Tuesday July 5th, decreasing $0.88 or 1.15 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb lost 0.94 percent. Over the last 12 months, its price rose by 13.97 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 74.76 by the end of this quarter and at 68.84 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
75.96
Daily Change
-1.15%
Yearly
13.97%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.93 0.13 0.08% 33.01%
Abbott 109.30 -0.92 -0.83% -8.01%
ALKERMES 31.43 0.90 2.95% 22.97%
Amgen 246.73 1.18 0.48% 1.26%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Astrazeneca 65.51 -0.44 -0.67% 9.37%
Biogen 212.58 1.95 0.93% -38.36%
Bristol-Myers Squibb 75.96 -0.88 -1.15% 13.97%
Coherus Biosciences 8.54 0.71 9.07% -37.34%
Catalent 105.99 -1.03 -0.96% -6.33%
Endo International 0.52 -0.05 -8.79% -88.21%
Gilead Sciences 62.34 -0.02 -0.03% -8.87%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Horizon Pharma 82.76 1.92 2.38% -13.59%
Intercept Pharmaceuticals 15.15 1.02 7.22% -20.43%
Jazz Pharmaceuticals 160.04 1.46 0.92% -12.51%
J&J 178.14 -1.38 -0.77% 6.05%
Lannett 0.58 0.02 2.73% -87.41%
Eli Lilly 327.18 2.47 0.76% 38.98%
Medtronic 90.49 -0.89 -0.97% -28.73%
Merck & Co 92.64 0.22 0.24% 18.60%
Novartis 80.91 -0.74 -0.91% -4.31%
Phibro Animal Health 20.15 0.56 2.86% -29.99%
Prestige Brands 59.78 0.20 0.34% 15.43%
Pfizer 51.64 -0.67 -1.28% 31.43%
Perrigo 40.80 -0.22 -0.54% -13.01%
Drreddys Laboratories 55.87 0.03 0.05% -24.86%
Regeneron Pharmaceuticals 596.56 1.16 0.19% 2.46%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Revance Therapeutics 14.73 0.40 2.79% -54.04%
Sanofi 97.12 -1.22 -1.24% 11.93%
Sanofi 50.18 -0.83 -1.63% -2.43%
Teva Pharmaceutical Industries 7.71 -0.18 -2.28% -19.77%
United Therapeutics 237.15 -0.85 -0.36% 28.00%
Zoetis 174.25 0.04 0.02% -10.19%

Indexes Price Day Year
US500 3835 6.06 0.16% -11.72%

Bristol-Myers Squibb
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.